Tumor stem cells in breast cancer

Ivanov A.A.; Popova O.P.; Kuznetsova A.V.; Danilova T.I.

doi:https://doi.org/10.17116/patol201577564-67

Ivanov A.A.

Nauchnyĭ tsentr serdechno-sosudistoĭ khirurgii im. A.N. Bakuleva RAMN, Moskva

Popova O.P.

GBOU VPO "Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova" Minzdravsotsrazvitiia Rossii, Moskva

Kuznetsova A.V.

FGBU "Institut biologii razvitiia im. N.K. Kol'tsova" RAN, Moskva

SPIN RSCI: 5274-4737
Scopus AuthorID: 13002619200
ORCID: 0000-0002-9567-351X

Danilova T.I.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation

Tumor stem cells in breast cancer

Authors:

Ivanov A.A., Popova O.P., Kuznetsova A.V., Danilova T.I.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2015;77(5): 64‑67

DOI: 10.17116/patol201577564-67

Read: 2700 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Ivanov AA, Popova OP, Kuznetsova AV, Danilova TI. Tumor stem cells in breast cancer. Russian Journal of Archive of Pathology. 2015;77(5):64‑67. (In Russ.)
https://doi.org/10.17116/patol201577564-67

Подписка 2026 Архив патологии (Russian Journal of Archive of Pathology)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

The effect of acetylamide synthetic peptide HLDF-6 on cell differentiation in breast cancer. Russian Journal of Archive of Pathology. 2025;(2):5-10

Treatment outcomes of stage IIA–IIB breast cancer patients of hormone-positive HER2-negative subtype after neoadjuvant polychemotherapy depending on Ki-67 levels. P.A. Herzen Journal of Oncology. 2025;(2):13-18

Repeated breast reconstruction after previous complications. Pirogov Russian Journal of Surgery. 2025;(6):51-57

Guidelines for assessing the quality of mammographic images. Russian Journal of Preventive Medicine. 2025;(6):21-32

Hematological indicators of the systemic inflammatory response in the prognosis of luminal HER2-negative breast cancer patients undergoing surgery followed by adjuvant therapy. P.A. Herzen Journal of Oncology. 2025;(3):31-38

Hemostasis disorders during neoadjuvant therapy in patients with breast cancer. P.A. Herzen Journal of Oncology. 2025;(3):39-44

Incidence of regional lymph node metastases in patients with early prognostically unfavorable molecular biological breast cancer. Pirogov Russian Journal of Surgery. 2025;(7):11-15

Autologous fat transplantation into post-lymphadenectomy cavity for prevention of lymphorrhea after total mastectomy. Pirogov Russian Journal of Surgery. 2025;(7):24-35

Biopsy of the sentinel lymph node and the possibility of performing breast-conserving surgery for the non-inflammatory invasive breast cancers with edema. P.A. Herzen Journal of Oncology. 2025;(4):96-101

Radiation damage to the lungs and heart in a patient after radiation therapy for breast cancer. Journal of Respiratory Medicine. 2025;(3):79-84

Abstract:

High mortality from breast cancer is associated with the high heterogeneity of tumor and the frequent recurrences of the pathological process, which are due to the presence of tumor stem cells. The review considers the biological properties of tumor stem cells, the molecular mechanisms of their regulation, interaction with the microenvironment, and their role in the heterogeneity of the morphological and clinical forms of breast cancer.

Keywords:

breast cancer

tumor heterogeneity

tumor stem cells

microenvironment